NFATc1-IN-1 |
| Catalog No.GC69552 |
NFATc1-IN-1 (compuesto A04) es un inhibidor efectivo de la formación de osteoclastos inducida por RANKL, con una IC50 de 1.57 μM. NFATc1-IN-1 muestra propiedades antiosteoclásticas al reducir la translocación nuclear de NFATc1 inducida por RANKL. Este compuesto puede ser utilizado en investigaciones sobre enfermedades óseas destructivas.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1912422-56-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for NFATc1-IN-1
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for NFATc1-IN-1
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *